Half-year report · Q2
2689.TEDINET S100V7MJ
Period2024-07-01 → 2024-12-31
Filed2025-02-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥60.6bn | 2024-07-01 → 2024-12-31 | Cons. | Net sales |
| Revenue | ¥118.6bn | 2023-07-01 → 2024-06-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥57.5bn | 2023-07-01 → 2023-12-31 | Cons. | Net sales |
| Operating income | ¥808m | 2024-07-01 → 2024-12-31 | Cons. | Operating income |
| Operating income | ¥747m | 2023-07-01 → 2023-12-31 | Cons. | Operating income |
| Ordinary income | ¥824m | 2024-07-01 → 2024-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥2.2bn | 2023-07-01 → 2024-06-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥746m | 2023-07-01 → 2023-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥816m | 2024-07-01 → 2024-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥745m | 2023-07-01 → 2023-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥648m | 2024-07-01 → 2024-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.5bn | 2023-07-01 → 2024-06-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥486m | 2023-07-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥648m | 2024-07-01 → 2024-12-31 | Cons. | Profit loss |
| Net income | ¥486m | 2023-07-01 → 2023-12-31 | Cons. | Profit loss |
| Total assets | ¥46.8bn | at 2024-12-31 | Cons. | Assets |
| Total assets | ¥43.2bn | at 2024-06-30 | Cons. | Assets |
| Total assets | ¥43.4bn | at 2023-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥35.3bn | at 2024-12-31 | Cons. | Liabilities |
| Total liabilities | ¥31.9bn | at 2024-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥11.5bn | at 2024-12-31 | Cons. | Net assets |
| Net assets / equity | ¥11.4bn | at 2024-06-30 | Cons. | Net assets |
| Net assets / equity | ¥10.2bn | at 2023-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.6bn | at 2024-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.7bn | at 2024-06-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥2.6bn | at 2024-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.7bn | at 2024-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.9bn | at 2023-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.4bn | at 2023-06-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥800m | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.1bn | 2023-07-01 → 2024-06-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥146m | 2023-07-01 → 2023-12-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥889m | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥673m | 2023-07-01 → 2024-06-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥347m | 2023-07-01 → 2023-12-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥1.5bn | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥1.1bn | 2023-07-01 → 2024-06-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥1.0bn | 2023-07-01 → 2023-12-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥109.44 | 2024-07-01 → 2024-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥251.68 | 2023-07-01 → 2024-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥81.01 | 2023-07-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 24.6% | at 2024-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 26.3% | at 2024-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 23.4% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 38
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2024-07-01 → 2024-12-31 | −¥880m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-07-01 → 2024-12-31 | −¥880m |
| Reconciling Itemsreconciling | segment profit | 2024-07-01 → 2024-12-31 | −¥67m |
| jpcrp040300-q2r_E02928-000Care Nursing Goodsreportable segment | revenue | 2024-07-01 → 2024-12-31 | ¥1.4bn |
| jpcrp040300-q2r_E02928-000Care Nursing Goodsreportable segment | revenue external | 2024-07-01 → 2024-12-31 | ¥1.4bn |
| jpcrp040300-q2r_E02928-000Care Nursing Goodsreportable segment | revenue intersegment | 2024-07-01 → 2024-12-31 | ¥19,000 |
| jpcrp040300-q2r_E02928-000Care Nursing Goodsreportable segment | segment profit | 2024-07-01 → 2024-12-31 | ¥105m |
| jpcrp040300-q2r_E02928-000Medical Equipmentreportable segment | revenue | 2024-07-01 → 2024-12-31 | ¥57.3bn |
| jpcrp040300-q2r_E02928-000Medical Equipmentreportable segment | revenue external | 2024-07-01 → 2024-12-31 | ¥56.5bn |
| jpcrp040300-q2r_E02928-000Medical Equipmentreportable segment | revenue intersegment | 2024-07-01 → 2024-12-31 | ¥816m |
| jpcrp040300-q2r_E02928-000Medical Equipmentreportable segment | segment profit | 2024-07-01 → 2024-12-31 | ¥715m |
| jpcrp040300-q2r_E02928-000SPDreportable segment | revenue | 2024-07-01 → 2024-12-31 | ¥2.8bn |
| jpcrp040300-q2r_E02928-000SPDreportable segment | revenue external | 2024-07-01 → 2024-12-31 | ¥2.8bn |
| jpcrp040300-q2r_E02928-000SPDreportable segment | revenue intersegment | 2024-07-01 → 2024-12-31 | ¥64m |
| jpcrp040300-q2r_E02928-000SPDreportable segment | segment profit | 2024-07-01 → 2024-12-31 | ¥55m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-07-01 → 2024-12-31 | ¥61.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-07-01 → 2024-12-31 | ¥60.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-07-01 → 2024-12-31 | ¥880m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-07-01 → 2024-12-31 | ¥875m |
| Reconciling Itemsreconciling | revenue | 2023-07-01 → 2023-12-31 | −¥725m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-07-01 → 2023-12-31 | −¥725m |
| Reconciling Itemsreconciling | segment profit | 2023-07-01 → 2023-12-31 | −¥76m |
| jpcrp040300-q2r_E02928-000Care Nursing Goodsreportable segment | revenue | 2023-07-01 → 2023-12-31 | ¥1.3bn |
| jpcrp040300-q2r_E02928-000Care Nursing Goodsreportable segment | revenue external | 2023-07-01 → 2023-12-31 | ¥1.3bn |
| jpcrp040300-q2r_E02928-000Care Nursing Goodsreportable segment | revenue intersegment | 2023-07-01 → 2023-12-31 | ¥1m |
| jpcrp040300-q2r_E02928-000Care Nursing Goodsreportable segment | segment profit | 2023-07-01 → 2023-12-31 | ¥102m |
| jpcrp040300-q2r_E02928-000Medical Equipmentreportable segment | revenue | 2023-07-01 → 2023-12-31 | ¥54.3bn |
| jpcrp040300-q2r_E02928-000Medical Equipmentreportable segment | revenue external | 2023-07-01 → 2023-12-31 | ¥53.6bn |
| jpcrp040300-q2r_E02928-000Medical Equipmentreportable segment | revenue intersegment | 2023-07-01 → 2023-12-31 | ¥656m |
| jpcrp040300-q2r_E02928-000Medical Equipmentreportable segment | segment profit | 2023-07-01 → 2023-12-31 | ¥669m |
| jpcrp040300-q2r_E02928-000SPDreportable segment | revenue | 2023-07-01 → 2023-12-31 | ¥2.6bn |
| jpcrp040300-q2r_E02928-000SPDreportable segment | revenue external | 2023-07-01 → 2023-12-31 | ¥2.5bn |
| jpcrp040300-q2r_E02928-000SPDreportable segment | revenue intersegment | 2023-07-01 → 2023-12-31 | ¥68m |
| jpcrp040300-q2r_E02928-000SPDreportable segment | segment profit | 2023-07-01 → 2023-12-31 | ¥52m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-07-01 → 2023-12-31 | ¥58.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-07-01 → 2023-12-31 | ¥57.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-07-01 → 2023-12-31 | ¥725m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-07-01 → 2023-12-31 | ¥823m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 522
| Item | Context | Value | Unit |
|---|---|---|---|
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E02928-000CareNursingGoodsReportableSegmentsMember | 1369959000 | JPY |
| Net sales | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 61507388000 | JPY |
| Net sales | CurrentYTDDuration_ReconcilingItemsMember | -879694000 | JPY |
| Net sales | CurrentYTDDuration | 60627694000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E02928-000MedicalEquipmentReportableSegmentsMember | 715007000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E02928-000SPDReportableSegmentsMember | 55041000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E02928-000CareNursingGoodsReportableSegmentsMember | 105326000 | JPY |
| Operating income | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 875375000 | JPY |
| Operating income | CurrentYTDDuration_ReconcilingItemsMember | -67254000 | JPY |
| Operating income | CurrentYTDDuration | 808120000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の５第１項の表の第１号 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)中国財務局長 | |
| Filing date cover page | FilingDateInstant | 2025-02-14 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第76期中(自 2024年７月１日 至 2024年12月31日) | |
| Company name cover page | FilingDateInstant | Original text (Japanese)オルバヘルスケアホールディングス株式会社 | |
| Company name in english cover page | FilingDateInstant | ＯＬＢＡ ＨＥＡＬＴＨＣＡＲＥ ＨＯＬＤＩＮＧＳ，Ｉｎｃ． | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 前島 洋平 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)岡山市北区下石井一丁目１番３号 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | ０８６－２３６－１１１５ | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)常務取締役管理本部長 村田 宣治 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)岡山市北区下石井一丁目１番３号 日本生命岡山第二ビル | |
| Telephone number nearest place of contact cover page | FilingDateInstant | ０８６－２３６－１１１５ | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)常務取締役管理本部長 村田 宣治 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E02928 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 26890 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)オルバヘルスケアホールディングス株式会社 | |
| Filer name in english | FilingDateInstant | OLBA HEALTHCARE HOLDINGS, INC. | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第四号の三様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | true | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | cte | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | － | |
| Current fiscal year start date | FilingDateInstant | 2024-07-01 | |
| Current period end date | FilingDateInstant | 2024-12-31 | |
| Type of current period | FilingDateInstant | Q2 | |
| Current fiscal year end date | FilingDateInstant | 2025-06-30 | |
| Previous fiscal year start date | FilingDateInstant | 2023-07-01 | |
| Comparative period end date | FilingDateInstant | 2023-12-31 | |
| Previous fiscal year end date | FilingDateInstant | 2024-06-30 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － | |
| Amendment flag | FilingDateInstant | false | |
| Identification of document subject to amendment | FilingDateInstant | － | |
| Report amendment flag | FilingDateInstant | false |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |